Transfusion support for haemophiliacs.
D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001787:Blood Group Incompatibility / Q000209:etiology; D001803:Blood Transfusion / Q000191:economics; D005164:Factor IX / Q000276:immunology / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000276:immunology / Q000628:therapy*; D002836:Hemophilia B / Q000150:complications / Q000276:immunology / Q000628:therapy; D006488:Hemostasis, Surgical; D006525:Hepatitis, Viral, Human / Q000209:etiology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D013923:Thromboembolism / Q000209:etiology; D065227:Transfusion Reaction
D000936:Antigen-Antibody Complex; D001779:Blood Coagulation Factors; C026912:cryoprecipitate coagulum; C025667:prothrombin complex concentrates; D005169:Factor VIII; D005164:Factor IX; D005340:Fibrinogen